March 2nd, 2015 · Leave a Comment
MANKATO, Minn. — Fall back, spring forward. We’ve all heard the saying, and it helps people remember which way to set their clocks for the start and end of Daylight Saving Time. Although it’d be nice to gain an hour of sleep twice a year, that’s not the case. Starting Sunday, March 8 at 2 a.m., we’ll all lose an hour. Altering your sleep schedule, or having poor sleep habits to begin with, can have a greater effect on your health than you may think.
“With Daylight Saving Time, we lose an hour of sleep, which causes significant fatigue in most people and can linger for days or weeks,” says Martha Yanci Torres, M.D., neurologist and sleep specialist at Mayo Clinic Health System in Mankato. “To minimize the impact, you can make gradual adjustments.”
She provides this advice:
“Regardless of the time of year, proper sleep is an essential part of life,” says Dr. Yanci Torres. “There are many benefits to practicing good sleep health, as well as risks for cutting sleep too short.”
February 9th, 2015 · Leave a Comment
By Dennis Douda
Alzheimer's Disease has been steadily encroaching into singer, songwriter Glen Campbell's life. Instead of retreating to deal with the challenges privately, Glen and his family decided to share their struggle with documentary filmmakers. The production called Glen Campbell: I'll Be Me by PCH Films, includes both heartwarming and candidly frank moments Mr. Campbell experienced during his visits to Mayo Clinic for care.
Ronald Petersen, M.D., Ph.D., director of the Mayo Clinic Alzheimer's Disease Research Center, praised the Campbell family for their determination to raise awareness about the condition's impact on patients, as well as their caregivers. [TRT 4:20]
*Special note: Glen Campbell and Julian Raymond won the Best Country Song Grammy Award for Glen's final song, "I'm Not Gonna Miss You," from the Academy nominated documentary, Glen Campbell: I'll Be Me.
Journalists: A broadcast quality video package is available in the downloads. Click here for full script.
October 6th, 2014 · Leave a Comment
A recent agreement between Wickenburg Community Hospital and Mayo Clinic in Arizona means the service featuring a remotely controlled, self-propelled robot is now available in Wickenburg.
Mayo Clinic was the first medical center in Arizona to do pioneering clinical research to study telemedicine as a means of serving patients with a stroke in neurologically underserved rural and urban settings, and today serves as the "hub" in a network of 15 other "spoke" centers in 4 states. Wickenburg Community Hospital is the 16th hospital to be part of the telestroke service from Mayo Clinic in Arizona. Read the rest of this entry »
September 17th, 2014 · Leave a Comment
By Jim McVeigh
PHOENIX — A smell test could someday be one of the tools to screen for people at risk of developing Parkinson’s disease, according to a new Mayo Clinic study.
Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually, sometimes starting with a barely noticeable tremor in just one hand. But while tremor may be the best-known sign of Parkinson's, the disorder also commonly causes stiffness and slowing of movement. Additionally, there are many non-movement problems, including constipation, loss of the sense of smell, sleep problems, lightheadedness, urinary difficulties, depression and anxiety. The non-movement symptoms can develop many years before movement disorders.
Although Parkinson's disease can't be cured, medications may markedly improve symptoms. Currently, there is no accurate diagnostic test for the disease; diagnosis is based on medical history, a review of signs and symptoms, a neurological and physical examination and by ruling out other conditions. Confirmation of the disease can only be made by performing an autopsy. Read the rest of this entry »
August 18th, 2014 · Leave a Comment
JACKSONVILLE, Fla. — Mayo Clinic’s stroke center in Jacksonville is the first center in Florida to receive national Comprehensive Stroke Center certification, joining an elite group of centers throughout the United States that are focused on providing advanced and complex stroke care.
Centers that achieve this distinction — awarded by The Joint Commission working with the American Heart Association and the American Stroke Association — are recognized as leaders that help set the national agenda in highly specialized stroke care. The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care.
Tags: cerebrovascular, Comprehensive Stroke Center, Dr. David Miller, Florida News Release, Interventional Radiology, Matthew Clark PhD, Mayo Clinic in Florida, Neurology, Neurosurgery, News Release, stroke, telestroke, The Joint Commission, MayoClinicFL
August 15th, 2014 · Leave a Comment
We have all experienced the annoying, relentless and throbbing pain associated with a headache. They can slow us down or even bring us to a complete stop. However, did you know that there are several different types of headaches, and knowing the type you've got can be the first step in effectively treating it?
July 21st, 2014 · Leave a Comment
By Jim McVeigh
PHOENIX — A new Mayo Clinic study suggests that the care and support family members give to elderly widows following the death of their spouse may be a factor in delaying dementia.
The study presented at the Alzheimer’s Association International Conference in Copenhagen, Denmark last week was designed to evaluate the effects of widowhood in people with mild cognitive impairment - a precursor of dementia. The thinking had been that widowhood would accelerate the development of dementia in people with MCI but the study showed the opposite.
Mayo Clinic researchers used data on more than 3,500 people from the National Alzheimer’s Coordinating Center database, which compiles information collected at various Alzheimer’s disease Centers in the U.S. The researchers found that of the 1,078 subjects who developed dementia, people who remained married developed dementia at a younger age than those who were widowed (83 years old versus 92 years).
July 16th, 2014 · Leave a Comment
A Third Protein Provides Clue
Since the time of Dr. Alois Alzheimer himself, two proteins (beta-amyloid (Aβ) and tau) have become tantamount to Alzheimer’s disease (AD). But a Mayo Clinic study challenges the perception that these are the only important proteins accounting for the clinical features of the devastating disease.
In a large clinico-imaging pathological study, Mayo Clinic researchers demonstrated that a third protein (TDP-43) plays a major role in AD pathology. In fact, people whose brain was TDP positive were 10 times more likely to be cognitively impaired at death compared to those who didn’t have the protein, showing that TDP-43 has the potential to overpower what has been termed resilient brain aging. The study was published in the journal Acta Neuropathologica.